Proscia and Ibex Medical Analytics are collaborating on software that powers artificial intelligence-enabled workflows for prostate cancer diagnosis.
The partnership is focused on integrating Ibex’s Galen Prostate solution and Proscia’s Concentriq image- and data-management platform to bring AI-powered triaging, cancer detection, and grading of prostate core needle biopsies into routine workflows.
Galen Prostate provides real-time quality control by alerting pathologists to misdiagnosed and misgraded cancers. Concentriq is used for routine image viewing, management, and analysis and serves as a launch pad for computational applications.
The integrated solution will make Galen Prostate available to Concentriq users, beginning with select customers in the United States and Europe.
